These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2375613)

  • 1. Novel irreversible aromatase inhibitors.
    di Salle E; Giudici D; Briatico G; Ornati G
    Ann N Y Acad Sci; 1990; 595():357-67. PubMed ID: 2375613
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione.
    Brandt ME; Puett D; Covey DF; Zimniski SJ
    J Steroid Biochem; 1988 Sep; 31(3):317-24. PubMed ID: 3419162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
    J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Steroids; 1987; 50(1-3):135-46. PubMed ID: 3504057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies with aromatase inhibitor 4-hydroxy-androstenedione.
    Brodie AM; Wing LY
    Steroids; 1987; 50(1-3):89-103. PubMed ID: 3504069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
    Santner SJ; Rosen H; Osawa Y; Santen RJ
    J Steroid Biochem; 1984 Jun; 20(6A):1239-42. PubMed ID: 6748639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of androgen aromatization in human breast cancer.
    Abul-Hajj YJ
    J Steroid Biochem; 1980 Dec; 13(12):1395-400. PubMed ID: 7464118
    [No Abstract]   [Full Text] [Related]  

  • 9. Selection of 19-(ethyldithio)-androst-4-ene-3,17-dione (ORG 30958): a potent aromatase inhibitor in vivo.
    Geelen JA; Deckers GH; van der Wardt JT; Loozen HJ; Tax LJ; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):181-8. PubMed ID: 1825923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
    Johnston JO; Wright CL; Holbert GW; Benson HD
    J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.
    Njar VC; Düerkop J; Hartmann RW
    J Enzyme Inhib; 1996; 10(1):47-56. PubMed ID: 8835929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH
    Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The inhibitory effect of miconazole on aromatase activity for androstenedione in human placental and ovarian preparations].
    Yamamoto T; Urabe M; Okada H
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1379-85. PubMed ID: 3443212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aromatase inhibitors: pharmacological aspects].
    de Crémoux P
    Bull Cancer; 2000 Dec; 87 Spec No():23-29. PubMed ID: 11250605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase.
    Johnston JO; Wright CL; Metcalf BW
    Endocrinology; 1984 Aug; 115(2):776-85. PubMed ID: 6745181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-1,4-androstadiene-3,17-dione (SH 489): characterization of an irreversible inhibitor of estrogen biosynthesis.
    Henderson D; Norbisrath G; Kerb U
    J Steroid Biochem; 1986 Jan; 24(1):303-6. PubMed ID: 3754599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor.
    Giudici D; Ornati G; Briatico G; Buzzetti F; Lombardi P; di Salle E
    J Steroid Biochem; 1988; 30(1-6):391-4. PubMed ID: 3386266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of aromatase by the enantiomers of aminoglutethimide and analogs.
    Ogbunude PO; Aboul-Enein HY
    Chirality; 1994; 6(8):623-6. PubMed ID: 7857773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors.
    Lesuisse D; Gourvest JF; Hartmann C; Tric B; Benslimane O; Philibert D; Vevert JP
    J Med Chem; 1992 May; 35(9):1588-97. PubMed ID: 1578485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.